Cosmo Chemical Co., Ltd. (005420.KS)
Seoul, KR
Cosmo Chemical Co., Ltd., founded in 1968 and headquartered in Incheon, South Korea, specializes in the production and distribution of titanium dioxide (TiO2) anatase. The company offers COTIOX KA-100, a versatile general-purpose TiO2 anatase grade, which is utilized as a white pigment in various products including plastics, rubbers, paints, papers, and bricks. It also finds application in electronic components like TV Braun tubes and MLCCs, as well as in catalysts and photo catalysts. For the textile sector, Cosmo Chemical provides COTIOX KA-320, a fiber-grade TiO2 anatase suitable for polyester filament, stable, and acryl fibers, in addition to its use in plastics and inks. Furthermore, the company supplies a range of ferrous sulfate products: ferrous sulfate heptahydrate, used in waste treatment agents, other materials, and catalysts; ferrous sulfate monohydrate, for waste treatment and other industrial purposes; liquid ferric sulfate, serving as a waste treatment agent for dyeing, leather, paper, food, and other industrial wastes; and liquid ferrous sulfate, applied in FENTON samples and other waste treatment processes. Their product portfolio also includes gypsum, employed in construction materials.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.34% | -4.89% | -22.96% | -16.87% | -16.38% | +2.01% | +2.23% | -70.77% | +46.80% | +300.35% | -83.66% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-11.3% Q1'26: +13.6% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+52.8% ★ Q1'26: +233.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+12.0% Q1'26: -24.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-2.5% Q1'26: +3.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%-1.8% Q1'26: +1.5% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×40.03× Q1'26: 8.93× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|---|---|
| Revenue |
431.65B
est: 267.80B (+61.2%)
|
678.09B
est: 679.00B (-0.1%)
|
406.82B
est: 668.00B (-39.1%)
|
355.50B
est: 908.00B (-60.8%)
|
512.61B
est: 995.00B (-48.5%)
|
718.19B
est: 705.40B (+1.8%)
|
798.98B
est: 1.02T (-21.5%)
|
749.28B
est: 1.57T (-52.4%)
|
| EBITDA |
58.35B
est: 14.98B (+289.4%)
|
24.53B
est: 37.99B (-35.4%)
|
16.84B
est: 37.38B (-54.9%)
|
14.95B
est: 50.81B (-70.6%)
|
58.55B
est: 55.67B (+5.2%)
|
68.56B
est: 39.47B (+73.7%)
|
27.03B
est: 56.95B (-52.5%)
|
-4.34B
est: 79.54B (-105.5%)
|
| EBIT |
37.16B
est: 3.01B (+1,135.6%)
|
-866.24M
est: 7.63B (-111.4%)
|
-10.28B
est: 7.50B (-237.1%)
|
-10.10B
est: 10.20B (-199.0%)
|
34.91B
est: 11.17B (+212.4%)
|
43.32B
est: 7.92B (+446.8%)
|
2.54B
est: 11.43B (-77.8%)
|
-34.95B
est: 18.83B (-285.7%)
|
| Net Income |
21.44B
est: 47.13B (-54.5%)
|
-15.89B
est: 3.57B (-545.0%)
|
-14.55B
est: 6.88B (-311.6%)
|
-23.87B
est: 26.22B (-191.0%)
|
10.89B
est: 41.17B (-73.6%)
|
11.24B
est: 19.60B (-42.6%)
|
-26.83B
est: 33.68B (-179.7%)
|
-64.68B
est: 55.80B (-215.9%)
|
| SGA |
13.57B
est: 6.66B (+103.6%)
|
14.04B
est: 16.90B (-16.9%)
|
11.10B
est: 16.62B (-33.2%)
|
10.03B
est: 22.60B (-55.6%)
|
13.72B
est: 24.76B (-44.6%)
|
16.62B
est: 17.56B (-5.3%)
|
18.31B
est: 25.33B (-27.7%)
|
17.53B
est: 38.14B (-54.1%)
|
| EPS |
1,167.79
est: 1,228.59 (-4.9%)
|
-745.26
est: 93.10 (-900.5%)
|
-635.28
est: 179.23 (-454.5%)
|
-785.17
est: 683.54 (-214.9%)
|
341.14
est: 1,073.03 (-68.2%)
|
327.60
est: 511.02 (-35.9%)
|
-753.82
est: 877.86 (-185.9%)
|
-1,690.80
est: 1,454.60 (-216.2%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex Energy&Chemicals 117460.KS | 0.58% | 97.8K | 0.45% |
| 2 | Kodex 200 Mid-Small 226980.KS | 0.30% | 40.8K | 0.30% |
| 3 | Kodex Secondary Battery Industry 305720.KS | 0.27% | 2.75M | 0.45% |
| 4 | Samsung Kodex Fn Growth ETF 325010.KS | 0.02% | 17.4K | 0.30% |
| 5 | Samsung KODEX 200 ETF 069500.KS | 0.02% | 2.86M | 0.15% |
| 6 | Kodex 200TR 278530.KS | 0.02% | 888.5K | 0.05% |
| 7 | Kodex KOSPI 226490.KS | 0.02% | 115.8K | 0.15% |
| 8 | Schwab International Small-Cap Equity ETF SCHC | 0.01% | 410.0K | 0.06% |
| 9 | Kodex Leverage 122630.KS | 0.00% | 233.0K | 0.64% |
| 10 | Kodex 200 USTN Balanced 284430.KS | 0.00% | 43.2K | 0.35% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| JaeYong Choi | CFO & Inside Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 005420.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
